Who is sponsoring NCT05141136?

NCT05141136 is sponsored by Gangnam Severance Hospital.

What drugs are being tested in NCT05141136?

Interventions in NCT05141136: Ultrasound probe sagittal group, Ultrasound probe transverse group.

What condition does NCT05141136 study?

NCT05141136 studies Cervical Spinal Stenosis.

Is NCT05141136 still recruiting?

NCT05141136 is currently status unknown. Last updated 2 December 2021.

Last reviewed 2021-12-02 · How we verify

NCT05141136

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Magnetic Resonance Imaging of Injectate in Thoracic 2 Paravertebral Block

Status unknown NA Last updated 2 December 2021

What this trial tests

NA trial testing Ultrasound probe sagittal group in Cervical Spinal Stenosis in 20 participants. Status unknown.

Timeline

30 November 2021

Primary endpoint
31 October 2023

31 October 2023

Quick facts

Lead sponsor	Gangnam Severance Hospital
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	single group
Masking	quadruple
Primary purpose	treatment
Enrollment	20
Start date	30 November 2021
Primary completion	31 October 2023
Estimated completion	31 October 2023
Sites	1 location across South Korea

Drugs / interventions tested

Ultrasound probe sagittal group
Ultrasound probe transverse group

Conditions studied

Cervical Spinal Stenosis — all drugs for Cervical Spinal Stenosis →

Sponsor

Gangnam Severance Hospital

Who can join

19 and older, any sex, with Cervical Spinal Stenosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to analyze the spread of local anesthetic using magnetic resonance imaging after thoracic 2 paravertebral block in patients with cervical radiculopathy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Cervical Spinal Stenosis

Currently open trials in the same condition.

NCT05786313 — Study of Individualized, Precise and Standardized Cervical Open-door Surgery for Cervical Spinal Stenosis · NA · recruiting
NCT05895968 — Researching the Useful of Barb Suture in Obese Patients Undergoing Posterior Cervical Surgery · NA · recruiting
NCT05767164 — Correlation Between Parameters and Prognosis of Cervical Single Open-door Surgery · NA · recruiting

Other Gangnam Severance Hospital trials

Trials by the same sponsor.

NCT07505628 — AI-based Rehabilitation for Hip and Knee Surgery Patients · NA · not yet recruiting
NCT07311122 — Endocrine Therapy Base on 21-gene RS · not yet recruiting
NCT07011823 — Immune-checkpoint Blockade After Partial Breast Irradiation by Pembrolizumab in Early TNBC · Phase 2 · not yet recruiting
NCT07211451 — Axillary Nodal Burden in HER2+ and TNBC · completed
NCT06839716 — Comparison of Ropivacaine-Poloxamer 407 Hydrogel and TAP Block for Postoperative Pain Management in Laparoscopic/Robotic · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05141136 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Gangnam Severance Hospital
Last refreshed: 2 December 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05141136.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing